Actively Recruiting

Age: 18Years +
All Genders
NCT06263920

Neurofrailty: A Study of Late-onset Epilepsy and Its Associations

Led by Lancashire Teaching Hospitals NHS Foundation Trust · Updated on 2025-04-08

360

Participants Needed

1

Research Sites

244 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

There is not much known about why some people develop seizures in adulthood, but some researchers think that it might be a warning from the body to highlight something may be wrong with the brain. A small number of people with first seizure in adulthood go on to experience problems like stroke or dementia later in life. However, stroke and dementia are common diseases, so it is not know whether there is a real association between these conditions. When people develop their first seizure in adult life, this is sometimes called Late-Onset Epilepsy. The NeuroFrailty study, will observe 'brain health' over the years following the onset of a seizure, to provide more information about people with these kinds of seizures.

CONDITIONS

Official Title

Neurofrailty: A Study of Late-onset Epilepsy and Its Associations

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of late-onset epilepsy or first seizure after age 18
  • Diagnosis confirmed or established at a tertiary neurology centre
  • Sequential cases will be used; an annual cap of 150 patients per year per cohort may apply
  • For control participants: established diagnosis of migraine
  • Control participants may be with or without therapeutic medications with antiepileptic properties
Not Eligible

You will not qualify if you...

  • Seizures caused by a lesion such as malignancy, stroke (excluding transient ischaemic attack), hypoxic brain injury, trauma, or vascular/congenital abnormalities likely causing seizures
  • For control participants: diagnosis of epilepsy or confirmed seizure
  • People with migraine or headache syndrome can be included in case group; seizure syndrome presence is mutually exclusive between case and control groups

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Lancashire Teaching Hospitals NHS

Preston, Lancashire, United Kingdom, PR2 9HT

Actively Recruiting

Loading map...

Research Team

J

Jasmine Wall, MB BChir

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here